Additional Information

Description

Anastrozole Tablets, 1 mg, are a non-steroidal aromatase inhibitor indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women. The active ingredient, anastrozole, functions by blocking the aromatase enzyme, which is responsible for the conversion of androgens to estrogens in peripheral tissues.

The 1 mg strength is designed for once-daily oral administration. Anastrozole is commonly used as first-line therapy in postmenopausal women with advanced or metastatic breast cancer and as adjuvant treatment following surgery and/or radiation. It is also utilized as a second-line therapy in patients whose disease has progressed following tamoxifen therapy.

The formulation is supplied in a bottle containing 30 tablets, offering a 30-day supply at standard dosing. Tablets are film-coated and intended to be swallowed whole with water. Consistent daily use is critical to maintaining therapeutic efficacy and achieving optimal suppression of estrogen production.